Introduction
Henoch-Schönlein Purpura (HSP) is a prevalent pediatric vasculitis characterized by small blood vessel inflammation. While the condition is primarily recognized by its distinct purpuric rash, gastrointestinal (GI) manifestations—including severe abdominal pain and bleeding—affect 50–75% of patients. Current treatments, such as glucocorticoids, often prove insufficient, and the underlying molecular mechanisms driving these GI symptoms remain poorly understood. Recent evidence suggests that gut microbiota dysbiosis and acid-sensing ion channels (ASICs) play significant roles in pain signaling. This study investigates the functional link between the HSP microbial landscape and the expression of ASIC3, a key pH-sensitive ion channel, within the brain-gut axis.
Methodology
The researchers employed a "human-to-rat" fecal microbiota transplant (FMT) model to isolate the microbiome's influence. Fecal samples were collected from six children with abdominal HSP and six age-matched healthy controls. To establish a controlled environment, "pseudo germ-free" rats were prepared using an antibiotic cocktail before being inoculated with the human fecal solutions for seven days.
The study utilized 16S rRNA gene sequencing (targeting the V3-V4 regions) to profile the donor microbiota. Phenotypic changes in the rats were assessed using the Abdominal Withdrawal Reflex (AWR) to measure visceral sensitivity and a charcoal meal transit test to evaluate intestinal motility. Finally, molecular analysis of the Dorsal Root Ganglion (DRG)—the primary relay for spinal pain signals—was conducted via qRT-PCR and Western blotting to quantify ASIC3 mRNA and protein levels.
Results
The analysis revealed a profound "diversity gap" in the microbiota of HSP patients. Compared to healthy controls, children with HSP exhibited significantly lower microbial richness and diversity across multiple indices, including Shannon and Simpson indices.
This dysbiosis directly influenced the physiological state of the recipient rats. Rats receiving the HSP microbiota (HSP-FMT group) demonstrated:
- Increased Visceral Sensitivity: Significantly higher AWR scores at distension pressures of 40, 60, and 80 mmHg ($P < 0.05$), indicating a lower pain threshold.
- Accelerated Intestinal Motility: A significantly higher intestinal propulsion rate ($P = 0.017$), mirroring the GI distress seen in human patients.
- Molecular Upregulation: Both ASIC3 mRNA ($P < 0.05$) and protein levels in the DRG were significantly elevated compared to the control group.
Discussion
The findings suggest that the "pain phenotype" of HSP is transferable via the gut microbiota. A key insight involves the overabundance of short-chain fatty acid (SCFA)-producing bacterial families, such as Lachnospiraceae and Lactobacilli, in HSP patients. While SCFAs are generally beneficial, their overproduction may lower local intestinal pH. As ASIC3 is a specialized pH sensor, this acidic environment likely "primes" or upregulates these channels in the DRG, leading to chronic hypersensitivity and altered motility. This highlights the brain-gut axis as a critical mediator of HSP symptoms.
Conclusion
This study establishes that gut microbiota dysbiosis in HSP patients stimulates ASIC3 expression in the spinal cord's DRG, subsequently affecting intestinal motility and pain sensitivity. These results identify the brain-gut axis as a promising therapeutic target. Future research should explore whether specific probiotics or pH-buffering interventions can dampen ASIC3 expression, providing much-needed relief for children suffering from severe HSP-related abdominal pain.
Summary updated